Table 3.
Comparison of multi-state Markov model projections and validation targets.
| Mean deviation from regional stratified model projections |
|||
|---|---|---|---|
| Regional validation targets | Northeast | South | West |
| CD4 during ART | |||
| ≥500 | −2.1% | 0.0% | −2.2% |
| 200–499 | 0.6% | 1.6% | −7.4% |
| <200 | 1.0% | 6.3% | −7.1% |
| Off-ART | 15.9% | 3.5% | 22.7% |
| Mortality | −4.4% | −11.8% | −18.4% |
ART: Antiretroviral treatment; CD4: CD4 T-lymphocyte cell count per µL.